Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/14/24 17:00 | 11/12/24 | IOVA | Health | BioPrd | Biological Products, (No Diag | Maynard Ryan D | CA | D | 2 | M.d | 876 | 8.76 | 0 | 100 | 8 | D | ||||||||||||||||
11/14/24 17:00 | 11/12/24 | IOVA | Health | BioPrd | Biological Products, (No Diag | Maynard Ryan D | CA | D | 2 | S.d | -876 | 8.76 | 0 | -100 | 8 | D | ||||||||||||||||
10/16/24 18:33 | 10/14/24 | IOVA | Health | BioPrd | Biological Products, (No Diag | Vogt Frederick G | CA | DO | Interim | 2 | M.d | 0 | 0.00 | 0 | 78 | 62 | 204 | D | ||||||||||||||
10/16/24 18:32 | 10/14/24 | IOVA | Health | BioPrd | Biological Products, (No Diag | Graf Finckenstein Friedrich | CA | O | Chief Me | 2 | M.d | 0 | 0.00 | 0 | 30 | 99 | 61 | D | ||||||||||||||
10/16/24 18:30 | 10/14/24 | IOVA | Health | BioPrd | Biological Products, (No Diag | Bilinsky Igor | CA | O | COO | 2 | M.d | 0 | 0.00 | 0 | 30 | 114 | 56 | D | ||||||||||||||
9/5/24 19:52 | 9/3/24 | IOVA | Health | BioPrd | Biological Products, (No Diag | Bellemin Jean-Marc | CA | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 23 | 397 | 29 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |